Open Access

[Corrigendum] HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma

  • Authors:
    • Yangzhi Qi
    • Gang Deng
    • Pengfei Xu
    • Huikai Zhang
    • Fanen Yuan
    • Rongxin Geng
    • Hongxiang Jiang
    • Baohui Liu
    • Qianxue Chen
  • View Affiliations

  • Published online on: December 27, 2022     https://doi.org/10.3892/or.2022.8473
  • Article Number: 36
  • Copyright : © Qi et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Rep 42: [Related article:] 2309–2322, 2019; DOI: 10.3892/or.2019.7343

Following the publication of this article, an interested reader drew to the authors' attention that, in Fig. 1F on p. 2311 showing a representative high-grade glioma specimen, the data were either duplicated or overlapping with the data featured in Fig. 1D, which showed a low-grade glioma specimen. After having consulted their original data, the authors have realized that the data for Fig. 1D were inadvertently selected incorrectly.

The corrected version of Fig. 1, now showing the correct data for the high-magnification high-grade glioma specimen in Fig. 1F, is shown on the next page. The authors sincerely apologize for the error that was introduced during the preparation of this figure, thank the Editor of Oncology Reports for granting them the opportunity to publish a Corrigendum, and are grateful to the reader for alerting them to this issue. The authors also regret any inconvenience that this mistake may have caused.

Related Articles

Journal Cover

February-2023
Volume 49 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qi Y, Deng G, Xu P, Zhang H, Yuan F, Geng R, Jiang H, Liu B and Chen Q: [Corrigendum] HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma. Oncol Rep 49: 36, 2023
APA
Qi, Y., Deng, G., Xu, P., Zhang, H., Yuan, F., Geng, R. ... Chen, Q. (2023). [Corrigendum] HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma. Oncology Reports, 49, 36. https://doi.org/10.3892/or.2022.8473
MLA
Qi, Y., Deng, G., Xu, P., Zhang, H., Yuan, F., Geng, R., Jiang, H., Liu, B., Chen, Q."[Corrigendum] HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma". Oncology Reports 49.2 (2023): 36.
Chicago
Qi, Y., Deng, G., Xu, P., Zhang, H., Yuan, F., Geng, R., Jiang, H., Liu, B., Chen, Q."[Corrigendum] HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma". Oncology Reports 49, no. 2 (2023): 36. https://doi.org/10.3892/or.2022.8473